drugset / Trial / NCT03559114
PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
Phase 3
Recruiting
1100 enrolled
Sunnybrook Health Sciences Centre
Sunnybrook Research Institute · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
This is a phase III, multi-centre, double blind, randomized controlled trial of patients with traumatic brain injury (TBI).
Timeline
- Start
- 2018-07-19
- Primary completion
- 2026-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dalteparin sodium | Other / unclassified | 5000 iu | Subcutaneous |